4.6 Article

Molecular dynamics study of the structural basis of dysfunction and the modulation of reactive oxygen species generation by pathogenic mutants of human dihydrolipoamide dehydrogenase

Journal

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Volume 538, Issue 2, Pages 145-155

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.abb.2013.08.015

Keywords

Lipoamide dehydrogenase; Mutation; Reactive oxygen species; Diaphorase; Molecular dynamics

Funding

  1. Hungarian Scientific Research Fund (OTKA) [81983]
  2. Young Investigator Research Grant of Semmelweis University
  3. Young Investigator Research Grant of the Centennial Foundation of Gedeon Richter Pharmaceutical, Plc.
  4. Bolyai Fellowship
  5. Hungarian Academy of Sciences [02001]

Ask authors/readers for more resources

Human dihydrolipoamide dehydrogenase (LADH, E3) is a component in the pyruvate-, alpha-ketoglutarate- and branched-chain ketoacid dehydrogenase complexes and in the glycine cleavage system. The pathogenic mutations of LADH cause severe metabolic disturbances, called E3 deficiency that often involve cardiological and neurological symptoms and premature death. Our laboratory has recently shown that some of the known pathogenic mutations augment the reactive oxygen species (ROS) generation capacity of LADH, which may contribute to the clinical presentations. A recent report concluded that elevated oxidative stress generated by the above mutants turns the lipoic acid cofactor on the E2 subunits dysfunctional. In the present contribution we generated by molecular dynamics (MD) simulation the conformation of LADH that is proposed to be compatible with ROS generation. We propose here for the first time the structural changes, which are likely to turn the physiological LADH conformation to its ROS-generating conformation. We also created nine of the pathogenic mutants of the ROS-generating conformation and again used MD simulation to detect structural changes that the mutations induced in this LADH conformation. We propose the structural changes that may lead to the modulation in ROS generation of LADH by the pathogenic mutations. (c) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available